Investor mix
14 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 14 | 100% |
Biopharma company focused on developing drugs that target apoptosis in diseases related to cancer and inflammation
14 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 14 | 100% |